CJC-1295 (No DAC) Cost Per mg — How to Compare Suppliers Fairly

At a glance: Evaluating CJC-1295 (No DAC) cost per mg

Comparing the cost of research peptides requires understanding the distinction between target gross mass and net bio-available peptide mass. A vial labeled as 2 mg or 5 mg of peptide rarely contains 100% active peptide sequences due to residual moisture, trifluoroacetic acid (TFA) salt counterions, and synthesis byproducts.

To establish a fair comparison, principal investigators must evaluate cost per effective milligram. This involves factoring in the vendor's third-party High-Performance Liquid Chromatography (HPLC) purity percentage and net peptide content (NPC) derived from Mass Spectrometry (MS) and elemental analysis.

PX1 Research provides fully transparent, lot-specific documentation for every batch of cjc no dac. By verifying exact counterion mass, residual moisture, and chromatogram purity, research laboratories can determine true economic value without risking assay variability or compromised data integrity.

What is CJC-1295 (No DAC) in laboratory research?

CJC-1295 (No DAC), also known as Modified GRF 1-29, is a synthetic 29-amino-acid peptide analog of Growth Hormone-Releasing Hormone (GHRH). It functions as a selective GHRH receptor agonist designed to stimulate the pulsatile secretion of endogenous growth hormone (GH) from the anterior pituitary gland.

In preclinical settings, researchers analyze cjc 1295 for its capacity to sustain elevated GH and downstream Insulin-like Growth Factor 1 (IGF-1) concentrations. Unlike the long-acting Drug Affinity Complex (DAC) variant, the non-DAC form exhibits a shorter biological half-life, mirroring physiological GHRH pulses closely without continuous baseline elevation.

In vitro and animal models frequently utilize GHRH analogs to investigate tissue repair mechanisms, cellular regeneration, protein synthesis pathways, and metabolic substrate oxidation. Because metabolic signaling cascades are highly sensitive to compound concentration, accurate mass verification is critical when executing dosage-dependent experimental trials.

The cost-per-mg formula: Calculating true peptide yield

Calculating the actual cost per milligram requires a simple three-step mathematical formula. Buying decisions based solely on total vial price frequently result in overpaying for inactive counterions, water weight, and residual salts.

To calculate true peptide yield, apply the following equation: Effective Mass (mg) = Labeled Mass (mg) × HPLC Purity (%) × Net Peptide Content (%). Once effective mass is established, divide the total order price by effective mass to find the true cjc-1295 (no dac) cost per mg.

For instance, a 5 mg vial with 98% HPLC purity and an 80% Net Peptide Content yields 3.92 mg of actual active peptide sequence (5 mg × 0.98 × 0.80 = 3.92 mg). Comparing this figure against a vendor providing 99% HPLC purity and 88% Net Peptide Content reveals that higher-grade, fully characterized reagents are often significantly more cost-effective per active milligram.

Why label mass does not equal active peptide content

Lyophilized peptide cakes contain more than just the target amino acid chain. During solid-phase peptide synthesis (SPPS), peptides are cleaved from resins using trifluoroacetic acid (TFA). Unless specialized salt exchange processes are conducted, TFA remains bound to basic amino acid residues as a salt counterion.

TFA counterions can account for 10% to 25% of the total dry weight of a lyophilized peptide powder. Additionally, hygroscopic peptide cakes absorb atmospheric moisture during packaging, adding an additional 3% to 8% in residual water mass.

When suppliers fail to report Net Peptide Content on their Certificate of Analysis (COA), laboratories pay full price for TFA counterions and water vapor. PX1 Research mandates complete elemental and quantitative testing across our entire catalog of research peptides so researchers know the exact active mass present in every vial.

How to verify purity and analytical COAs before buying

A valid Certificate of Analysis is the only objective proof of compound identity and purity. When evaluating suppliers, request or download lot-specific analytical reports prior to completing purchase orders. Reliable COAs must originate from accredited, independent third-party laboratories.

Inspect the High-Performance Liquid Chromatography (HPLC) chromatogram for single, sharp main peaks. Broad peaks or baseline noise indicate degraded sequence fragments or synthesis side-products. Ensure the primary peak area percentage meets or exceeds 98.0%.

Verify identity using Mass Spectrometry (MS). The observed mass peak on the electrospray ionization mass spectrometry (ESI-MS) report must match the theoretical molecular weight of CJC-1295 (No DAC) precisely (3288.7 Da). Finally, confirm that endotoxin levels are measured using a quantitative Limulus Amebocyte Lysate (LAL) assay, ensuring levels remain below standard cell-culture reactivity thresholds (<0.01 EU/µg).

Comparing CJC-1295 (No DAC) suppliers: Evaluation criteria

To streamline vendor selection, purchase managers should grade peptide sources across six structured criteria. Evaluating suppliers using standardized metrics eliminates guesswork and protects lab budgets from substandard Reagents.

1. Synthesis Provenance: Ensure compounds are synthesized in verified US facilities adhering to rigorous quality management systems.

2. Lot Traceability: Check that every vial features a unique batch/lot number directly linked to downloadable HPLC, MS, and endotoxin reports.

3. Net Peptide Content Transparency: Demand explicit counterion and moisture reporting to calculate true cjc-1295 (no dac) cost per mg accurately.

4. Endotoxin Limits: Ensure strict endotoxin testing (<0.05 EU/mg) to prevent non-specific immune responses in sensitive cell lines or animal models.

5. Cold-Chain Fulfillment: Verify fast dispatch and temperature-controlled packaging options to prevent thermal degradation during transit.

6. Customer Support: Confirm dedicated technical support capable of providing raw analytical data and handling commercial research inquiries promptly.

Evaluating combination protocols: CJC-1295 and Ipamorelin

In neuroendocrine and metabolic research, investigators frequently study combination models involving GHRH analogs and Ghrelin/Growth Hormone Secretagogue Receptor (GHSR) agonists. A primary example is the combined application of cjc ipamorelin.

While CJC-1295 (No DAC) acts on the GHRH receptor to stimulate GH synthesis, growth hormone-releasing peptides like Ipamorelin act via distinct GHSR pathways to amplify signal transduction. Preclinical studies indicate that co-administration yields a synergistic release of growth hormone superior to either compound administered in isolation.

When sourcing multiple research peptides for comparative or synergistic protocols, researchers should evaluate individual cost-per-mg values across all target compounds. Sourcing both GHRH and GHRP reagents from a single high-purity vendor ensures consistent lot purity, uniform buffering chemistry, and reduced shipping overhead. Explore our full range of GH-releasing research compounds via our research peptide directory.

Red flags when purchasing CJC-1295 (No DAC) online

The online research chemical market contains significant quality variations. Unscrupulous distributors frequently utilize deceptive marketing to mask poor manufacturing controls and substandard purity.

Be alert to vendors offering pricing dramatically below market average. Severe discounts often indicate unpurified crude peptides, re-labeled excess stock, or cakes containing excessive TFA and residual solvents.

Avoid vendors displaying static, generic COAs without batch numbers or dates. If a supplier cannot link a specific vial to an independent, lot-matched analytical report, the product should be rejected. Other critical red flags include missing endotoxin data, lack of direct phone or email support, and non-specific origin statements that hide overseas sourcing.

Why research labs source CJC-1295 (No DAC) from PX1 Research

PX1 Research is built specifically to serve academic, biotechnology, and institutional research facilities requiring uncompromising chemical integrity. Our manufacturing standards eliminate common variables that compromise experimental reproducibility.

Every batch of CJC-1295 (No DAC) undergoes full automated solid-phase synthesis in the United States, followed by multi-stage purification and lyophilization. We publish complete third-party HPLC, ESI-MS, and LAL endotoxin data for every single production run.

By providing accurate net peptide content metrics alongside raw chromatograms, PX1 Research empowers lab administrators to calculate exact cost per active milligram. Institutional buyers seeking bulk quantities can also review our wholesale research peptide program for volume pricing options.

Ordering CJC-1295 (No DAC) from PX1 Research

PX1 Research provides high-purity, lyophilized order 2 mg or 5 mg vials of CJC-1295 (No DAC) designed for immediate reconstitution in laboratory settings. Products ship in heavy-walled glass vials sealed under inert nitrogen atmosphere to preserve long-term peptide stability.

Orders placed before 3:00 PM EST Monday through Friday ship same-day from our dual distribution hubs located in California and Arizona. Expedited, fully tracked domestic shipping ensures minimal ambient exposure during transit.

Each order includes direct digital access to lot-specific analytical documentation. To verify live pricing, check current batch availability, or inspect full COAs, visit the official CJC-1295 (No DAC) product page.